| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 15 |
| 1 | BEVACIZUMAB | 12 |
| 2 | ACETAMINOPHEN | 7 |
| 3 | CAPECITABINE | 7 |
| 4 | CLOZAPINE | 6 |
| 5 | FLUOROURACIL | 6 |
| 6 | FLUOROURACIL CREAM, 0.5% | 6 |
| 7 | IRINOTECAN HYDROCHLORIDE | 6 |
| 8 | NIVOLUMAB | 6 |
| 9 | PANTOPRAZOLE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORPROMAZINE HYDROCHLORIDE | 3 | 0.0031 |
| 1 | LISOCABTAGENE MARALEUCEL | 2 | 0.0023 |
| 2 | BEVACIZUMAB-BVZR | 1 | 0.0014 |
| 3 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 3 | 0.0009 |
| 4 | FRUQUINTINIB | 3 | 0.0008 |
| 5 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | 3 | 0.0007 |
| 6 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 7 | AMISULPRIDE | 3 | 0.0005 |
| 8 | IRINOTECAN HYDROCHLORIDE | 6 | 0.0005 |
| 9 | ENFORTUMAB VEDOTIN | 3 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 3 | 0.0004 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 19 | 0.0002 |
| 2 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Cannabinoid [EPC] | 1 | 0.0001 |
| 5 | Typical Antipsychotic [EPC] | 3 | 0.0001 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 9 | Cholinergic Muscarinic Antagonist [EPC] | 3 | 0.0001 |